(19)
(11) EP 1 622 872 A1

(12)

(43) Date of publication:
08.02.2006 Bulletin 2006/06

(21) Application number: 04720668.5

(22) Date of filing: 15.03.2004
(51) International Patent Classification (IPC): 
C07D 215/14(1985.01)
C07D 215/12(1985.01)
C07D 401/04(1990.01)
C07D 409/12(1990.01)
C07D 413/12(1990.01)
C07D 403/06(1990.01)
C07D 413/06(1990.01)
C07D 417/06(1990.01)
C07D 215/50(1985.01)
C07D 241/42(1985.01)
C07D 401/12(1990.01)
C07D 405/12(1990.01)
C07D 417/12(1990.01)
C07D 401/06(1990.01)
C07D 405/06(1990.01)
(86) International application number:
PCT/IB2004/000836
(87) International publication number:
WO 2004/085401 (07.10.2004 Gazette 2004/41)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 28.03.2003 US 458274 P

(71) Applicant: Pfizer Products Inc.
Groton, Connecticut 06340 (US)

(72) Inventors:
  • CHANG, George, Pfizer Global R & D
    Groton, CT 06340 (US)
  • DIDIUK, Mary Theresa, Pfizer Global R & D
    Groton, CT 06340 (US)
  • FINNEMAN, Jari Ilmari, Pfizer Global R & D
    Groton, CT 06340 (US)
  • GARIGIPATI, Ravi Shanker, Pfizer Global R & D
    Groton, CT 06340 (US)
  • KELLEY, Ryan Michael, Pfizer Global R & D
    Groton, CT 06340 (US)
  • PERRY, David Austen, Pfizer Global R & D
    Groton, CT 06340 (US)
  • RUGGERI, Roger Benjamin, Pfizer Global R & D
    Groton, CT 06340 (US)
  • BECHLE, Bruce Michael, Pfizer Global R & D
    Groton, CT 06340 (US)
  • POLLASTRI, Michael, P.
    Waltham, MA 02453 (US)

(74) Representative: Ruddock, Keith Stephen et al
Pfizer Limited European Patents Department, Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) 1,2,4-SUBSTITUERTE 1,2,3,4-TETRAHYDRO-AND 1,2 DIHYDRO-QUINOLINE AND 1,2,3,4-TETRAHYDRO-QUINOXALINE DERIVATIVES AS CETP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROSIS AND OBESITY